Anterogen.Co.Ltd (065660) - Total Liabilities

Latest as of September 2025: ₩1.40 Billion KRW ≈ $951.49K USD

Based on the latest financial reports, Anterogen.Co.Ltd (065660) has total liabilities worth ₩1.40 Billion KRW (≈ $951.49K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Anterogen.Co.Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Anterogen.Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. See Anterogen.Co.Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Anterogen.Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Anterogen.Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Superkrane Mitra Utama Tbk PT JK:SKRN	Indonesia	Rp937.69 Billion
Sarana Mitra Luas JK:SMIL	Indonesia	Rp405.85 Billion
Hanmiglobal KO:053690	Korea	₩209.78 Billion
Tenaya Therapeutics Inc NASDAQ:TNYA	USA	$22.11 Million
P2 Gold Inc V:PGLD	Canada	CA$1.44 Million
SR Bancorp, Inc. Common stock NASDAQ:SRBK	USA	$959.00 Million
Hwashin Precision Engineering Co. Ltd KQ:126640	Korea	₩108.61 Billion
Stomil Sanok SA WAR:SNK	Poland	zł690.68 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Anterogen.Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Anterogen.Co.Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	41.75	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.02	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.02	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Anterogen.Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Anterogen.Co.Ltd (2014–2024)

The table below shows the annual total liabilities of Anterogen.Co.Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩5.87 Billion ≈ $3.98 Million	-70.65%
2023-12-31	₩19.99 Billion ≈ $13.54 Million	+15.25%
2022-12-31	₩17.34 Billion ≈ $11.75 Million	-12.57%
2021-12-31	₩19.83 Billion ≈ $13.44 Million	+50.98%
2020-12-31	₩13.14 Billion ≈ $8.90 Million	-18.91%
2019-12-31	₩16.20 Billion ≈ $10.98 Million	-64.29%
2018-12-31	₩45.37 Billion ≈ $30.75 Million	+293.48%
2017-12-31	₩11.53 Billion ≈ $7.81 Million	+721.17%
2016-12-31	₩1.40 Billion ≈ $951.53K	-24.04%
2015-12-31	₩1.85 Billion ≈ $1.25 Million	+22.79%
2014-12-31	₩1.51 Billion ≈ $1.02 Million	--

About Anterogen.Co.Ltd

KQ:065660 Korea Pharmaceuticals

Market Cap

$136.64 Million

₩201.62 Billion KRW

Market Cap Rank

#18081 Global

#800 in Korea

Share Price

₩25350.00

Change (1 day)

-5.76%

52-Week Range

₩20350.00 - ₩58000.00

All Time High

₩197700.00